ZA931539B - Indole derivatives. - Google Patents

Indole derivatives.

Info

Publication number
ZA931539B
ZA931539B ZA931539A ZA931539A ZA931539B ZA 931539 B ZA931539 B ZA 931539B ZA 931539 A ZA931539 A ZA 931539A ZA 931539 A ZA931539 A ZA 931539A ZA 931539 B ZA931539 B ZA 931539B
Authority
ZA
South Africa
Prior art keywords
pct
compounds
sec
nitrogen
disorders
Prior art date
Application number
ZA931539A
Other languages
English (en)
Inventor
John E Macor
Jolanta T Nowakowski
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ZA931539B publication Critical patent/ZA931539B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Addiction (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA931539A 1992-03-05 1993-03-04 Indole derivatives. ZA931539B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US84664092A 1992-03-05 1992-03-05

Publications (1)

Publication Number Publication Date
ZA931539B true ZA931539B (en) 1994-09-05

Family

ID=25298499

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA931539A ZA931539B (en) 1992-03-05 1993-03-04 Indole derivatives.

Country Status (30)

Country Link
US (2) US5594014A (OSRAM)
EP (1) EP0629199B1 (OSRAM)
JP (1) JPH07121943B2 (OSRAM)
KR (1) KR0179073B1 (OSRAM)
CN (4) CN1032309C (OSRAM)
AT (1) ATE218566T1 (OSRAM)
AU (1) AU666716B2 (OSRAM)
BR (1) BR9306012A (OSRAM)
CA (1) CA2117643C (OSRAM)
CZ (1) CZ282652B6 (OSRAM)
DE (1) DE69331988T2 (OSRAM)
DK (1) DK0629199T3 (OSRAM)
EG (1) EG20416A (OSRAM)
ES (1) ES2176199T3 (OSRAM)
FI (1) FI930968A7 (OSRAM)
HU (1) HU219489B (OSRAM)
IL (1) IL104941A (OSRAM)
MX (1) MX9301197A (OSRAM)
MY (1) MY109298A (OSRAM)
NO (1) NO302617B1 (OSRAM)
NZ (1) NZ249755A (OSRAM)
PL (1) PL172388B1 (OSRAM)
PT (1) PT629199E (OSRAM)
RU (1) RU2124012C1 (OSRAM)
SK (1) SK281938B6 (OSRAM)
TW (1) TW288010B (OSRAM)
UA (1) UA39866C2 (OSRAM)
WO (1) WO1993018032A1 (OSRAM)
YU (1) YU14893A (OSRAM)
ZA (1) ZA931539B (OSRAM)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5545644A (en) * 1990-10-15 1996-08-13 Pfizer Inc. Indole derivatives
US5578612A (en) * 1990-10-15 1996-11-26 Pfizer Inc. Indole derivatives
US5607951A (en) * 1990-10-15 1997-03-04 Pfizer Inc Indole derivatives
US5559246A (en) * 1990-10-15 1996-09-24 Pfizer Inc. Indole derivatives
US5559129A (en) * 1990-10-15 1996-09-24 Pfizer Inc Indole derivatives
US6380233B1 (en) 1992-04-07 2002-04-30 Pfizer Inc Indole derivatives as 5-HT1 agonists
AU670579B2 (en) 1992-04-07 1996-07-25 Pfizer Inc. Indole derivatives as 5-HT1 agonists
HUT75646A (en) * 1993-08-31 1997-05-28 Pfizer 5-arylindole derivatives and pharmaceutical compositions containing them
GB9417310D0 (en) 1994-08-27 1994-10-19 Pfizer Ltd Therapeutic agents
GB9420503D0 (en) * 1994-10-11 1994-11-23 Pfizer Ltd Therapeutic agents
GB9420529D0 (en) 1994-10-12 1994-11-30 Pfizer Ltd Indoles
EA199800611A1 (ru) 1995-12-29 1999-04-29 Берингер, Ингельхайм Фармасьютиклс, Инк. Производные фенилтиазола с противогерпетическими свойствами
US6288091B1 (en) 1995-12-29 2001-09-11 Boehringer Ingelheim Ltd. Antiherpes virus compounds and methods for their preparation and use
US5994352A (en) * 1998-11-13 1999-11-30 Pfizer Inc. 5-arylindole derivatives
CA2429850C (en) 2000-11-27 2008-12-30 Pfizer Products Inc. Ep4 receptor selective agonists in the treatment of osteoporosis
AU2002309585B2 (en) * 2001-04-20 2008-01-31 Wyeth Heterocyclylalkoxy-, -alkylthio- and -alkylaminobenzazole derivatives as 5-hydroxytryptamine-6 ligands
ITRM20020255A1 (it) * 2002-05-09 2003-11-10 Polifarma Spa Tautomero enolico dell'acido 3-indolilpiruvico, suoi sali e usi terapeutici.
ES2199086B1 (es) * 2002-07-31 2005-06-01 Cepa Schwarz Pharma Sl Nuevos derivados de cicloalcanodionas, procedimiento para su preparacion y sus aplicaciones farmacologicas.
GB0317229D0 (en) * 2003-07-23 2003-08-27 Pfizer Ltd Improved process
US20140206667A1 (en) 2012-11-14 2014-07-24 Michela Gallagher Methods and compositions for treating schizophrenia
CA3166940A1 (en) * 2020-02-04 2021-08-12 Abdelmalik Slassi 3-pyrrolidine-indole derivatives as serotonergic psychedelic agents for the treatment of cns disorders
PL243119B1 (pl) * 2020-04-16 2023-06-26 Univ Jagiellonski Rozpuszczalne w wodzie modyfikowane pochodne aminokwasowe nadające się do leczenia chorób o podłożu neurologicznym oraz zaburzeń psychiatrycznych

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA795239B (en) * 1978-10-12 1980-11-26 Glaxo Group Ltd Heterocyclic compounds
ZA815541B (en) * 1980-08-12 1983-03-30 Glaxo Group Ltd Heterocyclic compounds
GB8600397D0 (en) * 1986-01-08 1986-02-12 Glaxo Group Ltd Chemical compounds
GB8719167D0 (en) * 1987-08-13 1987-09-23 Glaxo Group Ltd Chemical compounds
GB8724912D0 (en) * 1987-10-23 1987-11-25 Wellcome Found Indole derivatives
GB8819024D0 (en) * 1988-08-10 1988-09-14 Glaxo Group Ltd Chemical compounds
IL96891A0 (en) * 1990-01-17 1992-03-29 Merck Sharp & Dohme Indole-substituted five-membered heteroaromatic compounds,their preparation and pharmaceutical compositions containing them
CA2042295A1 (fr) * 1990-05-15 1991-11-16 Jacques Chauveau Derives de mediateurs endogenes, leurs sels, procede de preparation, applications, et compositions les renfermant
KR100215627B1 (ko) * 1990-06-07 1999-08-16 레슬리 제인 에드워즈 치료용 헤테로사이클 화합물
RO111767B1 (ro) * 1990-10-15 1997-01-30 Pfizer Derivati de indol, procedee si intermediari pentru prepararea acestora, compozitii farmaceutice si metoda pentru tratarea unor afectiuni
US5208248A (en) * 1991-01-11 1993-05-04 Merck Sharpe & Dohme, Ltd. Indazole-substituted five-membered heteroaromatic compounds
SK278998B6 (sk) * 1991-02-01 1998-05-06 Merck Sharp & Dohme Limited Deriváty imidazolu, triazolu a tetrazolu, spôsob i
TW263508B (OSRAM) * 1991-02-12 1995-11-21 Pfizer

Also Published As

Publication number Publication date
CN1044910C (zh) 1999-09-01
EP0629199B1 (en) 2002-06-05
FI930968A7 (fi) 1993-09-06
DE69331988D1 (de) 2002-07-11
ES2176199T3 (es) 2002-12-01
CN1032309C (zh) 1996-07-17
CN1082044A (zh) 1994-02-16
RU2124012C1 (ru) 1998-12-27
PL172388B1 (pl) 1997-09-30
DE69331988T2 (de) 2002-09-19
RU94040914A (ru) 1996-08-10
MY109298A (en) 1996-12-31
CN1082815C (zh) 2002-04-17
IL104941A0 (en) 1993-07-08
EG20416A (en) 1999-02-28
MX9301197A (es) 1993-09-01
CZ212594A3 (en) 1995-06-14
ATE218566T1 (de) 2002-06-15
CA2117643A1 (en) 1993-09-16
PT629199E (pt) 2002-09-30
CZ282652B6 (cs) 1997-08-13
HU9300593D0 (en) 1993-05-28
CN1136566A (zh) 1996-11-27
IL104941A (en) 1998-06-15
CA2117643C (en) 2000-03-14
NZ249755A (en) 1996-08-27
DK0629199T3 (da) 2002-07-15
SK105294A3 (en) 1995-05-10
AU3733093A (en) 1993-10-05
JPH07121943B2 (ja) 1995-12-25
US5594014A (en) 1997-01-14
JPH07500353A (ja) 1995-01-12
NO943261D0 (no) 1994-09-02
TW288010B (OSRAM) 1996-10-11
US5717102A (en) 1998-02-10
WO1993018032A1 (en) 1993-09-16
SK281938B6 (sk) 2001-09-11
UA39866C2 (uk) 2001-07-16
NO943261L (no) 1994-09-02
EP0629199A1 (en) 1994-12-21
CN1044909C (zh) 1999-09-01
HUT64061A (en) 1993-11-29
BR9306012A (pt) 1997-11-18
NO302617B1 (no) 1998-03-30
KR950700291A (ko) 1995-01-16
CN1136432A (zh) 1996-11-27
CN1136565A (zh) 1996-11-27
HU219489B (hu) 2001-04-28
FI930968A0 (fi) 1993-03-04
KR0179073B1 (ko) 1999-03-20
AU666716B2 (en) 1996-02-22
YU14893A (sh) 1996-05-20

Similar Documents

Publication Publication Date Title
IL104941A0 (en) Indole derivatives
EG21209A (en) Indole derivatives
EG19647A (en) Neuroprotective indolone and related derivatives
EP0354777A3 (en) 3-(4-piperidine)-5-(2-sulfonylaminoethyl) indole derivatives
RU94045902A (ru) Производные ациламиноиндола в качестве 5-hti агонистов, фармацевтическая композиция и способ лечения
FI970149A0 (fi) Tiatsoli- ja tiadiatsoliyhdisteiden käyttö D3-reseptoriligandeina
CA2350089A1 (en) Indole derivatives
ES2070087A1 (es) Derivados de indol